Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,528 | -$21,254 | -$20,311 | -$16,095 |
| Dep. & Amort. | $305 | $641 | $628 | $614 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,631 | $1,549 | $2,052 | $2,184 |
| Change in WC | $4,897 | -$3,410 | -$1,487 | -$311 |
| Other Non-Cash | -$4,506 | -$509 | -$723 | -$1,042 |
| Operating Cash Flow | -$19,201 | -$22,983 | -$19,841 | -$14,650 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$600 | -$1,055 | -$511 | -$64 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$12,745 | -$6,073 | -$18,518 | -$14,852 |
| Inv. Sales/Matur. | $29,623 | $28,250 | $29,000 | $13,950 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $16,278 | $21,122 | $9,971 | -$966 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$33 | -$33 | -$33 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$4,183 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$37 | -$39 | $272 | $4,186 |
| Financing Cash Flow | -$37 | -$72 | $239 | -$30 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,960 | -$1,933 | -$9,631 | -$15,646 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,929 | $30,862 | $40,493 | $56,139 |
| End Cash | $25,969 | $28,929 | $30,862 | $40,493 |
| Free Cash Flow | -$19,801 | -$24,038 | -$20,352 | -$14,714 |